A Study to Compare Dysport® and Botox® in the Treatment of Cervical Dystonia
Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
1. to examine the non-inferiority of Dysport in the clinical efficacy and safety in
comparison with Botox®, assuming a bioequivalence ratio of 2.5:1 units, in the treatment
of Cervical dystonia.
2. double blind, randomised, multi center, crossover study
Phase:
Phase 4
Details
Lead Sponsor:
Seoul National University Hospital
Collaborators:
Ipsen Medical Research Collaborating Center, Seoul, Korea
Treatments:
abobotulinumtoxinA Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA